Timothy M. Kuzel
- Dermatology top 0.1%
- Cutaneous lymphoproliferative disorders research 61
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 31
- CAR-T cell therapy research 28
- Immunology top 0.5%
- T-cell and Retrovirus Studies 23
- Immunotherapy and Immune Responses 21
- Family Practice top 1%
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 44
-
- Renal cell carcinoma treatment 27
- Prostate Cancer Treatment and Research 21
- Co-authors
- Steven T. RosenJoan GuitartMadeleine DuvicCharles L. BennettFrancine M. FossYoun H. KimElise A. OlsenWalter M. Stadler
- Cited by
- DermatologyOncologyImmunology
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Investigation (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Timothy M. Kuzel
213 papers receiving 9.3k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Dermatology 2.0k
- Oncology 3.6k
- Immunology 2.6k
- Family Practice 202
- Pathology and Forensic Medicine 1.6k
Countries citing papers authored by Timothy M. Kuzel
This map shows the geographic impact of Timothy M. Kuzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy M. Kuzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy M. Kuzel more than expected).
Fields of papers citing papers by Timothy M. Kuzel
This network shows the impact of papers produced by Timothy M. Kuzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy M. Kuzel. The network helps show where Timothy M. Kuzel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Timothy M. Kuzel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 10 | |
| 4 | Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeuticsbreakdown → | 2023 | 131 |
| 5 | 2021 | 10 | |
| 6 | 2021 | 39 | |
| 7 | 2018 | 34 | |
| 8 | 2018 | 7 | |
| 9 | 2017 | 29 | |
| 10 | 2014 | 80 | |
| 11 | Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trialbreakdown → | 2014 | 865 |
| 12 | 2014 | 101 | |
| 13 | 2008 | 2 | |
| 14 | Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphomabreakdown → | 2007 | 776 |
| 15 | 2006 | 45 | |
| 16 | 2005 | 13 | |
| 17 | 2004 | 284 | |
| 18 | 2003 | 36 | |
| 19 | 2001 | 9 | |
| 20 | 1997 | 18 |
About Timothy M. Kuzel
Timothy M. Kuzel is a scholar working on Dermatology, Oncology and Immunology, having authored 220 papers that have together received 9.5k indexed citations. Recurring topics across this work include Cutaneous lymphoproliferative disorders research (61 papers), Lymphoma Diagnosis and Treatment (44 papers), Cancer Immunotherapy and Biomarkers (31 papers), CAR-T cell therapy research (28 papers), Renal cell carcinoma treatment (27 papers), T-cell and Retrovirus Studies (23 papers), Immunotherapy and Immune Responses (21 papers) and Prostate Cancer Treatment and Research (21 papers). The work is most often cited by research in Dermatology (2.0k citations), Oncology (3.6k citations) and Immunology (2.6k citations). Timothy M. Kuzel has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Steven T. Rosen, Joan Guitart, Madeleine Duvic, Charles L. Bennett, Francine M. Foss, Youn H. Kim, Elise A. Olsen, Walter M. Stadler, Henry H. Roenigk and Saby George. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.